Atlas Trials

Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma

Clinical trial NCT01182610 · TERMINATED

Trial details

NCT number
NCT01182610
Sponsor
Accelerated Community Oncology Research Network
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroesophageal AdenocarcinomaAdenocarcinoma of the Distal EsophagusAdenocarcinomas of the Gastroesophageal JunctionAdenocarcinoma of the Proximal Stomach
Start date
2011-04-01
Primary completion
2012-03-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.